The Vukuzazi programme was established to address public health responses and scientific priorities in light of the convergence of the HIV, tuberculosis and non-communicable disease epidemics in South Africa. The programme is a nested closed cohort of the Population Intervention Programme and performed community-based health phenotyping in the uMkhanyakude district of rural KwaZulu-Natal, South Africa, while simultaneously creating a data, image and bio-sample repository. Baseline data collection began in May 2018 and was completed in March 2020, having enrolled 50% of the eligible population aged 15 years and over [18 041: 12 230 female (68%) female and 5811 male (32%)]. The community-based phenotyping consisted of: a nurse-administered health questionnaire on personal history of HIV, tuberculosis, diabetes, hypertension, cancer, tobacco and alcohol use; quality of life; anthropometric measurements and blood pressure readings; venous blood sample for clinical testing and bio-banking; digital chest radiograph, sputum collection and sputum mycobacterial tests; as well as rectal swab collection for biobanking. Data for secondary analysis, access to the biological samples and imaging data are available through request on this link: [https://data.ahri.org]. In 2000, the Africa Centre Demographic Information System (ACDIS),1 a demographic surveillance platform, was established in the uMkhanyakude district of rural KwaZulu-Natal, one of the world's most intensely HIV-affected regions. Due to massive public health efforts that have increased access to antiretroviral therapy in this population over the past 15 years, HIV-associated mortality is declining and life expectancy is rising.2 Tuberculosis (TB) has overtaken HIV as the leading cause of mortality in South Africa,3 and non-communicable disease (NCD) morbidity and mortality are rising nationally4 and across sub-Saharan Africa.5 In response to the changing scientific and public health priorities posed by the intersection of the HIV, TB and NCDs epidemics, the Africa Health Research Institute (AHRI) expanded the Africa Centre Demographic Information System to form the Population Intervention Programme (PIP) in 2017.6 In 2018, Vukuzazi (‘Wake up and know yourself’ in isiZulu) was established as a nested closed cohort of PIP. Vukuzazi offered community-based health phenotyping and comprehensive bio-sampling to all resident adult (≥15 years) members of the southern part of the PIP study area, while building upon the existing wealth of demographic and HIV information collected over the previous 20 years. The objective of the programme was to determine the prevalence and overlap of infectious diseases and NCDs in the population 20 years into the HIV epidemic. Additionally, the programme aimed to create a data, image and bio-sample repository that could be used to understand the host, pathogen, social and environmental determinants of specific states of health and disease in the population, and provide the basis for follow-up intervention studies. The Vukuzazi programme was conducted in the southern part of the PIP area,6,(Figure 1) which corresponds with the original Africa Centre Demographic Information System surveillance area, near the market town of Mtubatuba. The area covers 438 km2 and includes a population of approximately 12 000 households with 65 000 residents (people who spend most of their nights in the surveillance area) and 30 000 non-residents (people who are household members but spend most of their nights outside the surveillance area). About ∼40% of resident members are younger than 15 years. Households in the southern PIP have been under continuous demographic surveillance since 2000.1 In 2003, annual HIV serosurveys were added to describe the demographic social and health impacts of the rapidly progressing HIV epidemic.1 The PIP area has 11 peripheral primary health care clinics (of which seven are in the southern part), and one district hospital lies outside the study area. The location of the area covered by the Vukuzazi programme, sites where the mobile camp enrolled participants and other features of the area are shown in Figure 1. Location of the study area, showing the Vukuzazi sites within the demographic surveillance area The scientific objectives and proposed activities of the Vukuzazi programme were conceptualized and developed in consultation with the AHRI Community Advisory Board (CAB) and other local stakeholders, including elected and traditional leaders and representatives of the local Department of Health (DoH). Ethical approval for the study was obtained from the Ethics Committees of the University of KwaZulu-Natal (BE560/17), London School of Hygiene & Tropical Medicine (#14722), the Partners Institutional Review Board (2018P001802), and from the University of Alabama at Birmingham (#300007237). The eligible study population consisted of all resident members of the southern PIP area who were aged ≥15 years during the baseline data collection (May 2018–March 2020). Non-resident members were excluded from participation. Participants were recruited in a two-stage process (Figure 2): (i) a household visit during which all eligible participants were invited to participate (the invitation process); and (ii) a formal informed consent and enrolment process at the Vukuzazi health camp (Figure 3). Components of the Vukuzazi programme The Vukuzazi mobile health camp This component was scheduled approximately 1 week before the Vukuzazi mobile health camp visited an area. We used the demographic surveillance data to populate an eligibility list, compiled by fieldworkers at the most recent household survey but no more than 1 year before the Vukuzazi visit. Based on this list, the community-based study team visited the household and invited all eligible members to the Vukuzazi health camp. The team explained the rationale for the study, using an information brochure written in isiZulu which was left with the household. Additionally, the team left personalized invitation cards for each eligible member which included the individual’s unique PIP identification number, a quick response (QR) barcode, appointment date and the location of the Vukuzazi mobile health camp. If no residents were home when a household was visited, three visit attempts were conducted before a household was considered non-contactable. During the 22-month study data collection period, the Vukuzazi mobile health camp moved through the PIP area with the goal of conducting procedures within two kilometres of all eligible homesteads. Vukuzazi camp sites were selected based on accessibility, sufficient space and mobile connectivity. Permission was sought from the local traditional authorities and leaders before selection of the final sites. The mobile health camp stayed on average 2 days at each location. In total, the camp was set up at 78 sites over the observation period (Figure 1). Participants presented to the health camp with their unique invitation card. After verification of their identity, they proceeded to the next station for the informed consent process and an explanation of the study components, including the risks and benefits of participation, as well as information about storage of samples for genetic analyses and future research. Those who consented were given a barcoded wristband which functioned as a unique identifier during their Vukuzazi camp interaction, checking their identifiers at each station. About 39 000 individuals were eligible 1 year before data collection. At the moment of data collection, about 3000 of them had died or moved out of the study area (Figure 4). This resulted in 36 097 individuals eligible for enrolment, of whom approximately three-quarters were contacted and accepted the invitation to visit the Vukuzazi mobile camp (about one-quarter were unable to be contacted, and of the contacted individuals only 2% refused the invitation). Among the 26 795 individuals who accepted the invitation, however, approximately one-quarter of eligible participants did not appear at the Vukuzazi camp, resulting in 18 041 individuals (50.0% of the eligible population) who enrolled in the Vukuzazi programme. Recruitment and participation in the Vukuzazi programme The Vukuzazi programme enrolled participants across the age range of the eligible population, with slight under-representation of the younger ages (Table 1). Females outnumbered males in the underlying population structure (Figure 5) and enrolled in higher proportions than males (Figure 6). Most participants resided in a rural (64%) or peri-urban (31%) area of the study area and had very high rates of unemployment (57%, Table 1). They were less highly educated, had lower rates of employment, were less likely to have out-migrated during the past 5 years and had a lower socioeconomic score compared with eligible non-participants. They were also more likely to have visited a clinic in the past year and to have ever consented to home-based HIV counselling and testing during the individual surveys (Table 1). Population pyramid of the eligible population and Vukuzazi participants (at time of invitation or recruitment) Contact and Vukuzazi health camp attendance rates by sex for eligible members of the demographic surveillance population Demographic characteristics of Vukuzazi participants, non-participants and eligible population Statistics presented: n (%). Statistical tests performed: chi square test of independence. Employment status calculated among members of the resident population in the labour force. Department of Statistics South Africa's strict definition of unemployment. Socioeconomic status: an asset-based index created using principal components analysis (PCA) on a standard list of questions about household items, water source, toilet type and electricity source. Demographic characteristics of Vukuzazi participants, non-participants and eligible population Statistics presented: n (%). Statistical tests performed: chi square test of independence. Employment status calculated among members of the resident population in the labour force. Department of Statistics South Africa's strict definition of unemployment. Socioeconomic status: an asset-based index created using principal components analysis (PCA) on a standard list of questions about household items, water source, toilet type and electricity source. Vukuzazi is nested within the AHRI PIP,6 which will allow for both demographic and health system follow-up of participants. Participants will be observed prospectively three times per year through the PIP demographic surveillance activities, which will record changes to their household residence, demographic and vital status. In addition, participants’ prospective clinical data will be collected through clinic and hospital data systems established through PIP.6,7 In 2017, AHRI implemented the ClinicLink system6,7 to collect the date of and self-reported reasons for all visits by individuals who attend one of the 11 clinics in the PIP area (whether self-referred or referred to care after screening tests). In this ClinicLink system, data are electronically captured and individuals are linked to their PIP identification number at the time of the visit. Data on all admissions to Hlabisa District Hospital (the local referral hospital) are collected through the Hospital Information System. Successful referrals or clinic attendance were monitored through ClinicLink. Successful referrals from Vukuzazi were entered into the relevant DoH care pathway by an AHRI professional nurse based at the health facility. Finally, in accordance with ongoing PIP activities, verbal autopsy will be performed for all deaths occurring in the population.6 These follow-up mechanisms allow Vukuzazi’s 2018–20 data to serve as a baseline assessment of a longitudinal cohort that includes clinical outcome assessment. Additional nested disease- and health behaviour-specific protocols will provide additional specific follow-up information.8 Long-term plans for the cohort will be driven both by scientific priorities and funding; currently we are considering repeating clinical measures every 3 to 5 years. The majority of measurements and samples were collected at the Vukuzazi mobile health camp; participants with abnormal measurements or results had a follow-up home visit with additional data collected at that time. The participant flow through the Vukuzazi mobile camp is summarized in Figure 3 and the data types collected during the two visits are described in Table 2. The mobile health camp consisted of module elements that could be used in parallel to accommodate up to 100 participants per day (Figure 3). Data collected at the Vukuzazi health camp, during the follow-up visit at home and through linkage with other systems TB, tuberculosis; WHO STEPS, World Health Organization STEPwise; COPD, chronic obstructive pulmonary disease; BMI, body mass index; MUAC, mid-upper arm circumference; urine beta-HCG, urine beta human chorionic gonadotropin; HIV Ab/Ag, HIV antibody/antigen; GeneXpert Mtb/RIF, GeneXpert Mycobacterium tuberculosis/Rifampin; CAD4TB, Computer-Aided Detection for TB; HbA1c, glycated haemoglobin; PIP, Population Intervention Programme; ICD-10, International Statistical Classification of Diseases and Related Health Problems 10th Revision; ART, antiretroviral therapy. Data collected at the Vukuzazi health camp, during the follow-up visit at home and through linkage with other systems TB, tuberculosis; WHO STEPS, World Health Organization STEPwise; COPD, chronic obstructive pulmonary disease; BMI, body mass index; MUAC, mid-upper arm circumference; urine beta-HCG, urine beta human chorionic gonadotropin; HIV Ab/Ag, HIV antibody/antigen; GeneXpert Mtb/RIF, GeneXpert Mycobacterium tuberculosis/Rifampin; CAD4TB, Computer-Aided Detection for TB; HbA1c, glycated haemoglobin; PIP, Population Intervention Programme; ICD-10, International Statistical Classification of Diseases and Related Health Problems 10th Revision; ART, antiretroviral therapy. After completing the informed consent procedure, participants submitted two self-administered rectal swabs, and women of childbearing age submitted a urine sample to ascertain pregnancy status. An enrolled nurse then administered a health questionnaire (see Supplementary material, available as Supplementary data at IJE online) on personal history of HIV, tuberculosis, diabetes, hypertension, cancer, tobacco and alcohol use,9 symptoms of TB (cough, fever, night sweats of any duration or unintended weight loss),10 and quality of life.11 Next, a research nurse performed anthropometric measurements (Table 2) and blood pressure readings following the World Health Organization STEPwise protocol.9 After 30 min of inactivity, three blood pressure measurements, with 5 min resting time in between, were collected using portable electronic devices (OMRON Healthcare, Model M6). Participants then moved to the blood station where 38.5 ml of blood was collected. All participants except for pregnant women underwent a digital chest X-ray (Canon CXDI-NE), performed in a mobile X-ray unit also equipped with an artificial intelligence computer-aided detection for TB (CAD4TB) score system (Version 5), which detects lung field abnormalities in real time.12 Any participant with one of the four cardinal TB symptoms, or a CAD4TB score above a pre-defined threshold or who was pregnant, was asked to submit a sputum sample. After completion of the chest X-ray and/or sputum collection, the visit to the health camp was completed at the exit station, where data were checked for completeness, and participants received a food parcel and reimbursement voucher (of the value of R 100—equivalent to approximately USD$6). All chest X-rays were interpreted by CAD4TBv5 and, within 14 days, underwent a standardized interpretation by an experienced radiologist. The study physician reviewed all data from questionnaires, anthropomorphic and blood pressure measurements and laboratory and radiological testing, and initiated appropriate clinical management. Participants with normal or expected findings (e.g. known HIV-positive on antiretroviral therapy with a suppressed viral load) received an SMS informing them that their results were normal. Participants who shared a phone or who had invalid test results received a phone call to ensure that the correct participant was contacted. Participants with abnormal findings (elevated blood pressure in someone not on antihypertensive treatment, or an X-ray suggestive of TB) or testing results (new HIV diagnosis, positive GeneXpert Mycobacterium tuberculosis/Rifampin (Xpert for MTB), glycated haemoglobin (HbA1c) >6.5%) were booked for an appointment for a home-based follow-up visit by a study nurse. At the follow-up visits, the following measurements were made (Table 2): three blood pressure measurements (performed as described above) for people with elevated blood pressure at the Vukuzazi health camp; and point-of-care fasting blood glucose for people with HbA1c >6.5%. On the basis of the Vukuzazi health camp results and, when appropriate, the repeated measurements, referrals were made for further care at one of the local primary health care clinics or hospital. In addition to the data collected through the Vukuzazi health camp, the following data on Vukuzazi participants are available through linkage with other data systems (Table 2): detailed demographic data (including education, socioeconomic status, marital status), sexual behaviour, household composition, structure and familial relationships (including family trees), household location (including geospatial coordinates), self-reported hospital attendance and diagnosis data, verbal autopsy data collected through the PIP surveillance,6 TB- and antiretroviral therapy-related data through Three Interlinked Electronic Register (TIER.net)13 and Covid-19-related data through the Covid-19 Surveillance protocol.8 The data generated from the Vukuzazi study will create a clinical research platform for future longitudinal studies of HIV, TB, NCDs and multimorbidity. Use of mobile clinics and mobile X-ray units for health screening the study to people within of their of residence, participation The study the of digital health as mobile data collection digital chest in clinical data for data and and with data collection. of electronic data collection is of of data from We were to test results and clinical of all participants, leading to linkage to care for participants with abnormal The of mobile data collection and data systems resulted in high rates of completion of study The on was also a from previous studies in the which have a to HIV and/or The range of considered have with participation in the of participant and in Vukuzazi that most participants had a positive of the research and their participation, they the health screening components over the research components and had of and as their for not Among the four HIV had the population prevalence TB was in TB in elevated blood pressure in and elevated blood glucose in of the and resulting of disease was for HIV and lower for elevated blood pressure tuberculosis and elevated blood glucose of the four diseases was across the life and of than one of the two were high and increased with Among the disease had the prevalence The HIV and non-communicable diseases also to have on quality of The of HIV was with self-reported health under This was in to having more (whether or which was with self-reported In South Africa and where non-communicable and infectious disease epidemics are into health care and the of care During the baseline survey we that of the population had TB, and that of individuals were with TB in community-based screening have symptoms, compared with people at health under TB traditional TB screening but in most is by chest X-ray In addition to TB through community-based screening have of radiological features compared with TB in clinics and a for imaging We positive of screening measurements of blood pressure and blood glucose to and when compared with testing on screening for and resulted in approximately a 50% of or referrals into the health for under These findings that repeated testing for NCDs be considered during community-based in when is for health systems with The Vukuzazi programme has that demographic surveillance be used to health of within a demographic surveillance area. The PIP surveillance a comprehensive to determine and participation and disease prevalence Data collected in Vukuzazi be linked to previous and prospective health and data collected as part of the annual The and of the linked data, image and bio-sample create the for further detailed studies into the biological and social determinants of health and disease in the population, and to We only enrolled of the eligible participants. Contact rates were among participants who were to and other social as times and on were enrolment rates of demographic (e.g. could be which to be considered in the interpretation of disease prevalence the existing wealth of information that has been collected on the eligible population since to the Vukuzazi participants and non-participants using to into This be in future analyses and follow-up studies. who to the data for secondary or the biological samples or imaging data, a of on this link: in which they their and the of the data or biological The Vukuzazi will on an ongoing basis and for Vukuzazi data are through the AHRI Data after approval and completion of a data Data including used for data collection and a data are available on the AHRI Data Supplementary data are available at IJE This research was in by the in part by the and and in part by the Africa Health Research the of the has a public to any from this We to the resident members of the AHRI PIP area, whom this study not have been We also to all at who made to the study from This study not have been the and of the KwaZulu-Natal Department of whom we with the We also all the members of the Vukuzazi (see Supplementary material, available as Supplementary data at IJE online) for their to this We this to the of Research who AHRI and the Vukuzazi Programme in are available as a Supplementary at IJE
No takes yet. Share an insight, caveat, or question.
Gunda et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: